LXRX
Lexicon Pharmaceuticals, Inc.
$2.16
AlphaVal Unavailable
AlphaVal: LXRX has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.